We announce the recently discovered incident regarding use, quality and relevant information of our bioresource. We have informed directly the users who have received the resource about the incident.
|Date||Name of a resource concerned||Incident||Measures taken|
|July 26, 2023||RCB1981 HD-Mar2 (Hodgkin lymphoma cell line)
RCB1435 KE-97 (Stomach cancer cell line)
|Derived cell type is different from the registered information of the depositor, respectively. (reference)||HD-Mar2 is distributed with the corrected characteristic information.
Distribution of KE-97 was stopped.
|July 26, 2023||RCB2712 MAEC (Mouse cell line)
RCB0752 TKD2 (Mouse cell line)
RCB2818 B1203L (Lung cancer cell line)
|There was an error in the characteristic information created in the cell bank, respectively. (reference)||All three cell lines are distributed with the corrected characteristic information.|
|August 1, 2019||RCB1293 SSP-25 (Human intrahepatic cholangiocarcinoma)||Different from the cell line described in the original paper. (reference)||Continue distribution with the precise information|
|October 24, 2018||RCB1156 Hepa-T1 (a cell line derived from Tilapia)
RCB0281 FRI-SpIm-1229 (a cell line derived from Lemyra imparilis)
RCB1733 LAH1 (a cell line derived from Pelophylax nigromaculatus)
RCB1735 LAH2 (a cell line derived from Pelophylax nigromaculatus)
|Derived from a different species. (reference)||Stop distribution of these 4 cell lines|
|March 12, 2015||RCB0179 23CLN (Bovine-derived cell line)||Derived from porcine but not bovine.(reference)||Stop provision of 23CLN for the moment|
|March 26, 2014||RCB2087 AZ521(Stomach cancer cell line)||Misidentification of HuTu80 (Duodenal cancer cell line) in ATCC. (reference)||There is no authentic stock of AZ521 and stop provision of AZ521|
|January 21, 2014||RCB1982 MOLT-17(Leukemia cell line)||Misidentification of an unknown cell line. (reference)||Replaced with RCB4561 MOLT-17 obtained from DSMZ|